FrancophonIA/ELRC3.0 huggingface dataset:
English: • feeling restless, abnormalities of thought, perception and levels of awareness, depression, feeling anxious, abnormal thinking, difficulty in sleeping
Croatian: • osjećaj nemira, abnormalne misli, percepcija i razine svijesti, depresija, osjećaj tjeskobe,
English: The risk/benefit ratio of mycophenolate mofetil in combination with sirolimus has not been established (see also section 4.5).
Croatian: Omjer rizika i koristi primjene mofetilmikofenolata u kombinaciji sa sirolimusom nije ustanovljen (vidjeti i dio 4.5).
English: If you stop taking Myfenax
Croatian: Ako prestanete uzimati Myfenax
English: There have been published reports of bronchiectasis in adults and children who received mycophenolate mofetil in combination with other immunosuppressants.
Croatian: Objavljeni su izvještaji o bronhiektazijama u odraslih i djece koji su primili mofetilmikofenolat u kombinaciji s drugim imunosupresivima.
English: When comparing rates of transplant rejection, rates of graft loss or adverse event profiles between mycophenolate mofetil patients with and without concomitant telmisartan medication, no clinical consequences of the pharmacokinetic drug-drug interaction were seen.
Croatian: Kada su se uspoređivale stope odbacivanja transplantata, stope gubitka presatka ili profili nuspojava između bolesnika liječenih mofetilmikofenolatom koji su istodobno primali telmisartan i onih koji nisu primali telmisartan, nisu primijećene kliničke posljedice farmakokinetičke interakcije između tih dvaju lijekova.
English: Gingival hyperplasia (≥1/100 to <1/10), colitis including cytomegalovirus colitis (≥1/100 to <1/10),
Croatian: Poremećaji probavnog sustava Hiperplazija gingive (≥1/100 do <1/10), kolitis, uključujući citomegalovirusni kolitis (često),
English: The first dose of oral Myfenax will be given to you at least 4°days after the transplant operation and when you are able to swallow oral medicines.
Croatian: Prvu dozu Myfenaxa za primjenu kroz usta primit ćete najkasnije 4 dana nakon presađivanja, kad budete sposobni gutati lijekove koji se primjenjuju kroz usta.
English: Patients with a body surface area greater than 1.5 m2 may be prescribed Myfenax capsules at a dose of 1 g twice daily (2 g daily dose).
Croatian: Bolesnicima tjelesne površine veće od 1,5 m2 mogu se propisivati Myfenax kapsule u dozi od 1 g dvaput dnevno (dnevna doza od 2 g).
English: • accumulation of fluid in the lung, shortness of breath, cough
Croatian: • nakupljanje tekućine u plućima, nedostatak zraka, kašalj
English: Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately 30% decrease of MPA concentrations.
Croatian: Istodobna primjena telmisartana i mofetilmikofenolata snizila je koncentracije MPA za približno 30%.
English: Do not take Myfenax,
Croatian: Nemojte uzimati Myfenax
English: • muscle weakness of the limbs, drooping or falling of the upper eyelid (myasthenic syndrome)
Croatian: • slabost mišića udova, spuštanje ili sklapanje gornje vjeđe (mijastenički sindrom) • poremećeni osjet okusa
English: The capsule cap is light blue opaque printed ‘M' axially in black ink.
Croatian: Kapica kapsule je neprozirna, svijetlo plava, s oznakom ‘M' uzdužno otisnutom crnom tintom.
English: If you forget to take Myfenax
Croatian: Ako ste zaboravili uzeti Myfenax
English: No dose adjustments are needed in patients experiencing delayed renal graft function post-operatively (see section 5.2).
Croatian: Kod bolesnika kod kojih nakon presađivanja dolazi do odgođene funkcije presađenog bubrega nisu potrebne prilagodbe terapijske doze (vidjeti dio 5.2).
English: Myfenax 250 mg Capsules
Croatian: Myfenax 250 mg kapsule
English: Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Croatian: Myfenax se preporučuje u kombinaciji s ciklosporinom i kortikosteroidima za profilaksu akutnog odbacivanja presatka u primatelja alogenog bubrežnog, srčanog ili jetrenog presatka.
English: Intravenous mycophenolate mofetil should be administered for the first 4°days following hepatic transplant, with oral Myfenax initiated as soon after this as it can be tolerated.
Croatian: Odrasli Intravenski oblik mofetilmikofenolata treba primjenjivati prva 4 dana nakon presađivanja jetre, a s primjenom Myfenax tableta treba započeti čim to dozvoljava bolesnikovo stanje.
English: Pharmacokinetic parameters were evaluated in 49 paediatric renal transplant patients (aged 2 to 18°years) given 600°mg/m2 mycophenolate mofetil orally twice daily.
Croatian: Farmakokinetički parametri ispitani su kod 49 pedijatrijskih bolesnika s bubrežnim presatkom (u dobi od 2 do 18 godina) koji su dvaput dnevno kroz usta primali 600 mg/m2 mofetilmikofenolata.
English: • alterations of the inner wall of the small intestine (intestinal villous atrophy)
Croatian: • promjene unutarnje stijenke tankog crijeva (atrofija crijevnih resica)
English: The first dose will be given within 5 days following the transplant operation.
Croatian: Prvu dozu primit ćete najkasnije 5 dana nakon presađivanja.
English: Precautions to be taken before handling or administering the medicinal product Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Myfenax capsules should not be opened or crushed to avoid inhalation or direct contact with skin or mucous membranes of the powder contained in Myfenax capsules.
Croatian: Budući da je mofetilmikofenolat pokazao teratogene učinke kod štakora i kunića, Myfenax kapsule ne smiju se otvarati ni drobiti, kako bi se izbjeglo udisanje ili izravan kontakt kože ili sluznica s praškom sadržanim u Myfenax kapsulama.
English: In a single dose study (6 subjects/group), mean plasma MPA AUC observed in subjects with severe chronic renal impairment (glomerular filtration rate < 25°mL/min/1.73°m2) were 28-75% higher relative to the means observed in normal healthy subjects or subjects with lesser degrees of renal impairment.
Croatian: U ispitivanju jedne doze (6 ispitanika/skupina), srednje vrijednosti AUC-a MPA u plazmi ispitanika s teškim kroničnim oštećenjem bubrega (brzina glomerularne filtracije < 25 ml/min/1,73 m2) bile su 28 - 75% više u odnosu na srednje vrijednosti koje su primijećene kod normalnih, zdravih ispitanika ili ispitanika s blažim stupnjevima bubrežnog oštećenja.
English: Changes to Myfenax therapy should only be undertaken under appropriate supervision in transplant recipients in order to minimise the risk of graft rejection (see section 4.8).
Croatian: U transplantiranih primatelja promjene u liječenju Myfenaxom trebaju biti pod odgovarajućim nadzorom kako bi se smanjio rizik od odbacivanja presatka (vidjeti dio 4.8).
English: Male patients of reproductive potential should be made aware of and discuss the potential risks of fathering a child with a qualified health-care professional.
Croatian: Muške bolesnike reproduktivne dobi kvalificirani zdravstveni radnik treba upoznati i s njima razgovarati o mogućim rizicima povezanima sa začećem djeteta.
English: No substantial alteration of MPA pharmacokinetics is anticipated and mycophenolate mofetil dose adjustment is not required.
Croatian: Ne očekuje se znatna promjena farmakokinetike MPA pa nije potrebna prilagodba doze mofetilmikofenolata.
English: Heart Transplant
Croatian: Presađivanje srca
English: In patients with renal impairment in whom Myfenax and ganciclovir or its prodrugs, e.g. valganciclovir, are co-administered the dose recommendations for ganciclovir should be observed and patients monitored carefully.
Croatian: Kod bolesnika s oštećenjem bubrega kod kojih se istodobno primjenjuju Myfenax i ganciklovir ili njegovi predlijekovi, npr. valganciklovir, treba razmotriti primjenu preporučene doze ganciklovira i pažljivo nadzirati bolesnika.
English: Skin cancer, benign neoplasm of skin
Croatian: vrlo često često karcinom kože, dobroćudna neoplazma kože
English: Myfenax 500 mg film-coated tablets are available in PVC/PVdC-aluminium blisters in pack sizes of 50 or 150 or 50 x 1 tablets per carton.
Croatian: Myfenax 500 mg filmom obložene tablete dostupne su u PVC/PVdC -aluminij blisterima u pakiranju od 50 ili 150 ili 50 x 1 tableta, u kutiji.
English: Mycophenolate mofetil has been associated with an increased incidence of digestive system adverse events, including infrequent cases of gastrointestinal tract ulceration, haemorrhage and perforation.
Croatian: Primjena mofetilmikofenolata povezuje se s povećanom incidencijom nuspojava vezanih uz probavni sustav, uključujući manje česte pojave ulkusa gastrointestinalnog trakta, krvarenja i perforacije.
English: MPA AUC values across age groups were similar in the early and late post-transplant period.
Croatian: Vrijednosti AUC-a MPA u ranom su i kasnom razdoblju nakon presađivanja bile slične u svim dobnim skupinama.
English: Patients receiving immunosuppressive regimens involving combinations of medicinal products, including Myfenax, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.8).
Croatian: Bolesnici koji primaju imunosupresivnu terapiju koja obuhvaća kombinaciju lijekova, uključujući Myfenax, izloženi su povećanom riziku od nastajanja limfoma i drugih zloćudnih bolesti, osobito kože (vidjeti dio 4.8).
English: Myfenax film-coated tablets should be handled with care.
Croatian: Myfenax filmom obloženim tabletama rukujte oprezno.
English: No substantial alteration of MPA pharmacokinetics is anticipated and Myfenax dose adjustment is not required.
Croatian: Ne očekuje se znatna promjena farmakokinetike MPA pa nije potrebna prilagodba doze Myfenaxa.
English: Note: 501 (2°g mycophenolate mofetil daily), 289 (3°g mycophenolate mofetil daily) and 277 (2°g intravenous/3°g oral mycophenolate mofetil daily) patients were treated in Phase III studies for the prevention of rejection in renal, cardiac and hepatic transplantation, respectively.
Croatian: Napomena: u fazi III ispitivanja sprječavanja odbacivanja bubrežnog, srčanog odnosno jetrenog presatka liječeno je 501 (2 g mofetilmikofenolata dnevno), 289 (3 g mofetilmikofenolata dnevno) odnosno 277 (2 g intravenskog / 3 g oralnog mofetilmikofenolata dnevno) bolesnika.
English: Myfenax 250 mg hard capsules are available in PVC/PVdC-aluminium blisters in pack sizes of 100 or 300 or 100 x 1 capsules per carton.
Croatian: Myfenax 250 mg tvrde kapsule dostupne su u PVC/PVdC -aluminij blisterima u pakiranju od 100 ili 300 ili 100 x 1 kapsula, u kutiji.
English: When comparing rates of transplant rejection or rates of graft loss between mycophenolate mofetil patients taking PPIs vs. mycophenolate mofetil patients not taking PPIs, no significant differences were seen.
Croatian: Uspoređujući stope odbacivanja transplantata ili stope gubitka presatka između bolesnika koji su uzimali mofetilmikofenolat i IPP naspram bolesnika koji s mofetilmikofenolatom nisu uzimali IPP, nisu primijećene značajne razlike.
English: Myfenax treatment should not be initiated in women of child bearing potential without providing a pregnancy test result to rule out unintended use in pregnancy (see section 4.6).
Croatian: Liječenje lijekom Myfenax ne smije se započeti kod žena reproduktivne dobi bez predočenja nalaza testa na trudnoću kako bi se isključila mogućnost nehotične primjene u trudnoći (vidjeti dio 4.6).
English: In patients with delayed renal graft function post-transplant, mean MPA AUC (0-12°h) was comparable to that seen in post-transplant patients without delayed graft function.
Croatian: Kod bolesnika kod kojih nakon presađivanja dolazi do odgođene funkcije presađenog bubrega srednji AUC (0-12 h) MPA mogao se usporediti s AUC-om MPA bolesnika kod kojih nakon presađivanja nije došlo do odgođene funkcije presađenog bubrega.
English: The patient information pack should contain:
Croatian: Paket s informacijama za bolesnike mora sadržavati: • Uputu o lijeku
English: Pregnancy, puerperium and perinatal conditions Cases of spontaneous abortions have been reported in patients exposed to mycophenolate mofetil, mainly in the first trimester, see section 4.6.
Croatian: U bolesnica izloženih mofetilmikofenolatu prijavljeni su slučajevi spontanog pobačaja, prvenstveno u prvom tromjesečju trudnoće, vidjeti dio 4.6.
English: • inflammation of the colon which causes abdominal pain or diarrhoea (sometimes caused by cytomegalovirus), ulcer of the stomach and/or duodenum, inflammation of the stomach,
Croatian: • upala debelog crijeva koja uzrokuje bol u trbuhu ili proljev (ponekad je uzrokuje citomegalovirus),
English: Congenital malformations have been observed post-marketing in children of patients exposed to mycophenolate mofetil in combination with other immunosuppressants, see section 4.6.
Croatian: Nakon stavljanja lijeka u promet primijećene su kongenitalne malformacije u djece bolesnica izloženih mofetilmikofenolatu u kombinaciji s drugim imunosupresivima (vidjeti dio 4.6).
English: Read the package leaflet before use.
Croatian: Prije uporabe pročitajte uputu o lijeku
English: Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder
Croatian: Nositelj odobrenja za stavljanje lijeka u promet i proizvođači Nositelj odobrenja za stavljanje lijeka u promet
English: Package leaflet: Information for the user Myfenax 500mg film-coated tablets
Croatian: Uputa o lijeku: Informacije za korisnika Myfenax 500 mg filmom obložene tablete mofetilmikofenolat
English: Liver Transplant
Croatian: Presađivanje jetre
English: Congenital malformations, including reports of multiple malformations, have been observed postmarketing in children of patients exposed to mycophenolate in combination with other immunosuppressants during pregnancy.
Croatian: Nakon stavljanja lijeka u promet prijavljene su kongenitalne malformacije, uključujući višestruke malformacije, kod djece bolesnica koje su bile izložene mikofenolatu u kombinaciji s drugim imunosupresivima tijekom trudnoće.
English: Transparent PVC/PVdC - aluminium blisters in pack sizes of 100 or 300 or 100 x 1 capsules per carton.
Croatian: Prozirni PVC/PVdC - aluminij blisteri sa 100 ili 300 ili 100 x 1 kapsula, u kutiji.
English: Each capsule contains 250 mg mycophenolate mofetil.
Croatian: Jedna kapsula sadrži 250 mg mofetilmikofenolata.
English: Myfenax should not be given to women of childbearing potential who are not using highly effective contraception (see section 4.6).
Croatian: Myfenax ne smije se davati ženama reproduktivne dobi koje ne koriste visoko učinkovite metode kontracepcije (vidjeti dio 4.6).
English: Myfenax tablets should only be prescribed to patients with a body surface area greater than 1.5°m2, at a dose of 1°g twice daily (2°g daily dose).
Croatian: Myfenax tablete propisuju se samo bolesnicima tjelesne površine veće od 1,5 m2 u dozi od 1 g dvaput dnevno (dnevna doza od 2 g).
English: • During your entire treatment with Myfenax
Croatian: • čitavo razdoblje liječenja lijekom Myfenax
English: • fit, increased tension of the muscles, shaking, sleepiness, feeling dizzy, headache, tingling, pricking or numbness
Croatian: • napadaj, povećana mišićna napetost, drhtanje, pospanost, omaglica, glavobolja, trnci, bockanje ili utrnulost
English: In patients with renal impairment in whom mycophenolate mofetil and ganciclovir or its prodrugs, e.g. valganciclovir, are co-administered the dose recommendations for ganciclovir should be observed and patients monitored carefully.
Croatian: Kod bolesnika s oštećenjem bubrega kod kojih se istodobno primjenjuju mofetilmikofenolat i ganciklovir ili njegovi predlijekovi, npr. valganciklovir, treba razmotriti primjenu preporučene doze ganciklovira i pažljivo nadzirati bolesnika.
English: In some of these cases switching mycophenolate mofetil to an alternative immunosuppressant resulted in serum IgG levels returning to normal.
Croatian: U nekima od tih slučajeva zamjena mofetilmikofenolata drugim imunosupresivom rezultirala je vraćanjem razine serumskog
English: Myfenax is contraindicated during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection.
Croatian: Myfenax je kontraindiciran tijekom trudnoće, osim ako ne postoji prikladno alternativno liječenje kojim bi se spriječilo odbacivanje presatka.
English: • low/high blood pressure, widening of blood vessels
Croatian: • ubrzani otkucaji srca • nizak/visoki krvni tlak, proširenje krvnih žila
English: Therefore Myfenax is contraindicated in pregnancy unless there are no suitable alternative treatments to prevent transplant rejection.
Croatian: Stoga je Myfenax kontraindiciran tijekom trudnoće, osim ako ne postoje prikladni alternativni načini liječenja kojima bi se spriječilo odbacivanje presatka.
English: CsA interferes with MPA enterohepatic recycling, resulting in reduced MPA exposures by 30-50% in renal transplant patients treated with mycophenolate mofetil and CsA compared with patients receiving sirolimus or belatacept and similar doses of mycophenolate mofetil (see also section 4.4).
Croatian: A smanjuje izloženost MPA-u za 30-50% u usporedbi s bolesnicima koji primaju sirolimus ili belatacept i slične doze mofetilmikofenolata (vidjeti i dio 4.4).
English: The following undesirable effects cover adverse reactions from clinical trials The principal adverse reactions associated with the administration of mycophenolate mofetil in combination with ciclosporin and corticosteroids include diarrhoea, leucopenia, sepsis and vomiting and there is evidence of a higher frequency of certain types of infections (see section 4.4).
Croatian: Glavne nuspojave, vezane uz primjenu mofetilmikofenolata u kombinaciji s ciklosporinom i kortikosteroidima, su proljev, leukopenija, sepsa i povraćanje, a dokazana je veća učestalost određenih vrsta infekcija (vidjeti dio 4.4).
English: Myfenax should not be used during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection (see section 4.6).
Croatian: Myfenax ne smije se koristiti u trudnoći, osim ako ne postoji prikladno alternativno liječenje kojim bi se spriječilo odbacivanje presatka (vidjeti dio 4.6).
English: Mean plasma MPAG AUC (0-12°h) was 2-3-fold higher than in post-transplant patients without delayed graft function.
Croatian: Srednja vrijednostAUC (0-12 h) MPAG-a u plazmi bio je 2-3 puta veća nego kod bolesnika kod kojih nakon presađivanja nije došlo do odgođene funkcije presatka.
English: Black ink containing: shellac, black iron oxide (E172), propylene glycol and potassium hydroxide.
Croatian: Crna boja koja sadrži: šelak, crni željezov oksid (E172), propilenglikol i kalijev hidroksid.
English: Advice that patients should not donate blood during therapy or for at least 6 weeks following discontinuation of mycophenolate.
Croatian: Savjet o tome da bolesnici ne smiju darivati krv tijekom liječenja ili najmanje 6 tjedana nakon prekida primjene mikofenolata.
English: Men must not donate semen during treatment with Myfenax and for at least 90°days after stopping treatment.
Croatian: Muškarci ne smiju donirati spermu tijekom liječenja lijekom Myfenax i najmanje 90 dana nakon prestanka liječenja.
English: You are a woman who is not capable of becoming pregnant if any of the following applies to you:
Croatian: U slučaju da se bilo koji od sljedećih navoda odnosi na Vas, Vi ste žena koja ne može ostati trudna:
English: Each tablet contains 500 mg mycophenolate mofetil.
Croatian: Jedna tableta sadrži 500 mg mofetilmikofenolata.
English: • vomiting, stomach pain, diarrhoea, feeling sick
Croatian: • povraćanje, bol u trbuhu, proljev, mučnina
English: Oral Myfenax should be initiated within 72°hours following transplantation.
Croatian: Myfenax tablete treba uzeti u roku od 72 sata nakon presađivanja.
English: Capsule content Pregelatinised starch (maize) Povidone K-30
Croatian: Sadržaj kapsule prethodno gelirani kukuruzni škrob povidon K-30 umrežena karmelozanatrij magnezijev stearat
English: • Abnormalities of the ear (e.g. abnormally formed or absent external ear), external auditory canal atresia (middle ear);
Croatian: • abnormalnosti uha (npr. abnormalan oblik ili izostanak vanjskog), atrezija vanjskog zvukovoda
English: Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation and infections caused by polyomaviruses (BK virus associated nephropathy, JC virus associated progressive multifocal leukoencephalopathy PML).
Croatian: ili hepatitisa C i infekcije uzrokovane polioma virusima (nefropatija povezana s BK virusom i progresivna multifokalna leukoencefalopatija (PML) povezana s JC virusom).
English: This means taking 4 capsules in the morning then 4 capsules in the evening.
Croatian: To znači da se 4 kapsule uzimaju ujutro, a
English: Myfenax 250 mg hard capsules
Croatian: Myfenax 250 mg tvrde kapsule
English: Acidosis, hyperkalaemia, hypokalaemia, hyperglycaemia, hypomagnesaemia, hypocalcaemia, hypercholesterolaemia, hyperlipidaemia, hypophosphataemia, hyperuricaemia, gout, anorexia Psychiatric disorders Very commonCommon
Croatian: Poremećaji metabolizma i prehrane vrlo često često acidoza, hiperkalijemija, hipokalijemija, hiperglikemija, hipomagnezijemija, hipokalcijemija, hiperkolesterolemija, hiperlipidemija, hipofosfatemija, hiperuricemija, giht, anoreksija
English: Film-coated tablets
Croatian: Filmom obložene tablete:
English: The systemic exposure at these levels is approximately equivalent to or less than 0.5°times the clinical exposure at the recommended clinical dose of 2 g/day for renal transplant patients and approximately 0.3°times the clinical exposure at the recommended clinical dose of 3 g/day for cardiac transplant patients (see section 4.6).
Croatian: Sistemska izloženost na tim razinama otprilike je ekvivalentna ili manja od 0,5 puta od kliničke izloženosti pri preporučenoj kliničkoj dozi od 2 g/dan za bolesnike s presađenim bubregom i otprilike 0,3 puta od kliničke izloženosti pri preporučenoj kliničkoj dozi od 3 g/dan kod bolesnika s presađenim srcem (vidjeti dio 4.6).
English: • if you are a woman who could be pregnant and you have not provided a negative pregnancy test before your first prescription, as mycophenolate causes birth defects and miscarriage.
Croatian: • ako ste žena koja bi mogla zatrudnjeti, a niste predočili negativan nalaz testa na trudnoću prije nego što
English: • constipation, indigestion, wind (flatulence), belching
Croatian: • zatvor, loša probava, vjetrovi (nadutost), podrigivanje
English: Therefore women of childbearing potential must use at least one form of reliable contraception (see section 4.3) before starting Myfenax therapy, during therapy, and for six weeks after stopping the therapy, unless abstinence is the chosen method of contraception.
Croatian: Stoga žene reproduktivne dobi moraju prije započinjanja liječenja, tijekom liječenja i još šest tjedana nakon prekida liječenja lijekom Myfenax koristiti najmanje jedan pouzdan oblik kontracepcije (vidjeti dio 4.3), osim ako je kao metoda kontracepcije odabrana apstinencija.
English: No data are available for cardiac or hepatic transplant patients with severe chronic renal impairment.
Croatian: Nema podataka o primjeni u bolesnika s presađenim srcem ili jetrom i s teškim kroničnim oštećenjem bubrega.
English: Do not take Myfenax if you are breast-feeding.
Croatian: Nemojte uzimati Myfenax ako dojite.
English: Oral Myfenax should be initiated within 5 days following transplantation.
Croatian: Myfenax tablete treba primijeniti u roku od 5 dana nakon presađivanja.
English: The recommended daily dose is 6°tablets (3°g of the active ingredient) taken as 2°separate doses.
Croatian: Preporučena dnevna doza je 6 tableta (3 g djelatne tvari) koje se uzimaju u 2 odvojene doze.
English: • fever, feeling of coldness, pain, feeling unwell, feeling weak and feeble
Croatian: • zadržavanje tekućine u tijelu • vrućica, osjećaj hladnoće, bol, loše osjećanje, osjećaj slabosti i iznemoglosti
English: • inflammation of the liver, yellowing of the skin and whites of the eyes
Croatian: • upala jetre, žuta boja kože i bjeloočnica
English: Transparent PVC/PVdC-aluminium blisters in pack sizes of 50 or 150 or 50 x 1 tablets per carton.
Croatian: Prozirni PVC/PVdC-aluminij blisteri sa 50 ili 150 ili 50 x 1 tableta, u kutiji.